[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![HottestStockNow Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::106823467.png) Hottest Stocks Now [@HottestStockNow](/creator/twitter/HottestStockNow) on x 2691 followers
Created: 2025-06-30 09:17:52 UTC

HUTCHMED and AstraZeneca: China OKs ORPATHYS in Combination with TAGRISSO for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy  $HCM, #HUTCHMED, $AZN, #AstraZeneca 


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1939614351742390493/c:line.svg)

**Related Topics**
[manat](/topic/manat)
[$hcm](/topic/$hcm)
[china](/topic/china)
[azn astrazeneca](/topic/azn-astrazeneca)
[stocks](/topic/stocks)
[$azn](/topic/$azn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/HottestStockNow/status/1939614351742390493)